<code id='470A522F50'></code><style id='470A522F50'></style>
    • <acronym id='470A522F50'></acronym>
      <center id='470A522F50'><center id='470A522F50'><tfoot id='470A522F50'></tfoot></center><abbr id='470A522F50'><dir id='470A522F50'><tfoot id='470A522F50'></tfoot><noframes id='470A522F50'>

    • <optgroup id='470A522F50'><strike id='470A522F50'><sup id='470A522F50'></sup></strike><code id='470A522F50'></code></optgroup>
        1. <b id='470A522F50'><label id='470A522F50'><select id='470A522F50'><dt id='470A522F50'><span id='470A522F50'></span></dt></select></label></b><u id='470A522F50'></u>
          <i id='470A522F50'><strike id='470A522F50'><tt id='470A522F50'><pre id='470A522F50'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:3151
          Lauren Gavron walking with prosthetic in a lab at the University of Pittsburgh. Courtesy Nathan Langer/UPMC & Pitt Health Sciences

          For years, Lauren Gavron relied on oxycodone to quiet the pain in her missing lower left limb. But she hated the fog that came with it, preventing her from feeling comfortable enough to drive.

          When researchers at the University of Pittsburgh delivered electric jolts to her spine in 2021, the Duquesne, Pennsylvania resident was shocked to feel that pain temporarily melt away — and to feel sensation in her prosthetic foot, improving her walk and balance.

          advertisement

          “You really wouldn’t believe it,” Gavron, 67, said. “As soon as the pain would start, it just all went away.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO
          Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

          MollyFerguson/STATThisweek,apreviewoftheTUDCAstudyinALSandthoughtsonhowitmightimpactAmylyxPharmaceut

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          Why Eli Lilly’s earnings didn’t quite live up to the hype

          KristofferTripplaar/APEventually,theluckiestcompaniesgettodealwithaveryparticularproblem:whattodowhe